A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see pentetic acid), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues as well as lesions with abnormal vascularity in the head and neck. Also used to facilitate the visualization of lesions with abnormal vascul...
Vanderbilt Childeen's Hospital, Nashville, Tennessee, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
National Taiwan University Hospital, Taipei, Taiwan
Bracco Imaging, Milan, Italy
Fudan University Huashan Hospital, Shanghai, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The 1st Affiliated Hosp of the 4th Military Med Uni, Xi'an, Shaanxi, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.